NCT03179189

Brief Summary

The pathophysiology and treatment of sepsis disease are still not fully known. International guides often refer to the studies done in the developed countries and suggest some treatments. The infrastructure of the developing countries is quite different. For this reason, it is not exactly scientific how much these proposals are reflected in patient treatment. In our study, We will try to reveal the treatment of sepsis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 6, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 7, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

October 1, 2017

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2017

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
Last Updated

September 29, 2017

Status Verified

September 1, 2017

Enrollment Period

1 month

First QC Date

June 6, 2017

Last Update Submit

September 27, 2017

Conditions

Sepsis

Outcome Measures

Primary Outcomes (1)

  • sepsis mortality

    90 day

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility Details18 years and over
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

propective chort

You may qualify if:

  • year old over

You may not qualify if:

  • Non-life expectant Those who live longer than 24 hours not that consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ataturk education research izmir

Izmir, Karabaglar, 35360, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Sepsis

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD,Critical care

Study Record Dates

First Submitted

June 6, 2017

First Posted

June 7, 2017

Study Start

October 1, 2017

Primary Completion

November 1, 2017

Study Completion

March 1, 2018

Last Updated

September 29, 2017

Record last verified: 2017-09

Locations

TU(1)